🌟D2R is seeking a strategic and collaborative leader to join our team as Associate Director, Indigenous Health Research for D2R. This role supports Indigenous-led health research, fosters strong partnerships with Indigenous communities & organizations and more! Learn more: buff.ly/zxV3Uxx
🔊 #D2RProjectSpotlight: D2R - Health Data Science (D2R-HeDS) platform 💡 Scientific Director: Guillaume Bourque (@McGillu) 🔗 Learn more: buff.ly/qDphDDy
#RNA #RNATherapy #RNAResearch
#D2RProjectSpotlight: End to end sequencing platform for RNA therapeutics quality control (EESPRNATQC) Scientific Director: Ioannis Ragoussis (@mcgillu)🔗 Learn more here: buff.ly/zhzGYc7
🔊 #D2RProjectSpotlight: Centre for Applied Nanomedicine (CAN)💡 Scientific Director: Janusz Rak (RI-MUHC)🧬 Centre for Applied Nanomedicine (CAN) is a place/platform where specialized instruments measure, observe, and characterize myriads of small objects known as nanoparticles 🔗 buff.ly/Hv3NYJV
#BlackHistoryMonth D2R held a webinar on Anti-Black Racism in Health Research. It examined how slavery and anti-Black racism in Canada shaped inequities in health research & the systemic barriers that continue to influence scientific inquiry and health outcomes today. Watch here: buff.ly/uaYFjZA
#D2RProjectSpotlight: RNA therapies for the treatment of a rare neurological disease led by Jo Anne Stratton (@mcgillu) This project aims to understand how RNA-based therapies can be optimized to target Schwann cells, the major cell type affected in Neurofibromatosis type 2.🔗 buff.ly/QYf2Kfg
🔊 #D2RProjectSpotlight: RNA therapeutics to block USP15-driven neuroinflammation in the brain led by Philippe Gros (@mcgillu) this project aims to test the capacity of these USP15 modalities to block neuroinflammation in vivo following delivery to the brain. Learn more: buff.ly/P0QfkgL
🔊 #D2RProjectSpotlight: mRNA Therapy to Prevent Liver Disease Progression in Zellweger Spectrum Disorder led by Nancy Braverman (@McGillu) ZSD is a rare genetic disorder, most patients harbor mutations in PEX1 gene. This project aims to restore PEX1 function. Learn more: buff.ly/3Y93ZQY
🔊 #D2RProjectSpotlight: Aptamer-short hairpin RNA conjugation for gene therapy against HIV led by Anne Gatignol (Jewish General Hospital)🧬This research aims to support a more effective procedure in which a person's own cells are modified to make them resistant to HIV.🔗 buff.ly/WudYn1G
🔊 #D2RProjectSpotlight: Lipid Nanoparticles for Nasal mRNA Vaccines💡 Led by Larry Lands (RI-MUHC) 🧬 This project explores delivering RNA vaccines through a nose spray. This nasal method is not only more convenient but could offer better protection for the lungs. 🔗 Learn more: buff.ly/raSze21
On #WorldCancerDay, we are reminded why research matters. D2R supports research across many types of #cancer, because whether they affect millions or thousands, every diagnosis deserves attention. #cancerresearch #cancerawareness #knowledgetocure
🔊 #D2RProjectSpotlight: 3’UTR engineering for next-generation T cell mRNA therapeutics led by Thomas Duchaine (@mcgillu) This project aims to improve cancer immunotherapies by designing “smart” RNA switches that control how long therapeutic mRNAs stay active in immune cells. buff.ly/iyMZTzA
🔊 #D2RProjectSpotlight: Development of RNA therapeutics against USP15-dependent neuroinflammation led by Philippe Gros, PhD🧬This project aims to develop inhibitors of USP15 which can dampen neuroinflammation using an RNA therapeutics approach. 🔗 Learn more: buff.ly/o3CRrRl
🔊 #D2RProjectSpotlight: Targeting MET exon 14 skipping variant in the early metastatic dissemination in lung cancer 🧬 Led by Morag Park (@mcgillgci.bsky.social) this project aims a novel therapy using targeted molecules designed to block this mutation. 🔗 buff.ly/VfPel6h
#D2RProjectSpotlight: Injectable Hydrogel/mRNA-LNP Platform for In Vivo CAR-T Cell Engineering 🧬Led by Guojun Chen (@McGillu) this project aims to accelerate the development of next-generation immunotherapies buff.ly/Xa2wnaT
#D2RProjectSpotlight: Transient CAR-T Cell engineering🧬Led by Taha Azad (@USherbrooke) this project aims to produce safe & effective CAR-Ts, and help accelerate RNA-based cell therapy development buff.ly/Tsz4eBD
#D2RProjectSpotlight: Development of a new blood test to track treatment success and to detect melanoma returning early🧬Led by Ian Watson (@mcgillu) this project aims to improve care for melanoma patients. buff.ly/7cVwU65
🔊#D2RProjectSpotlight: From #RNA to personalized #lungdisease treatment
🧬Led by David Langlais (@mcgill.ca), this project aims to identify blood markers for earlier diagnosis and personalized treatment of interstitial lung disease (ILD).
🔗https://shorturl.at/yXxOO
#RNA #RNAtherapies
🎯 Want to stay connected to the D2R community?
📩 Subscribe to our newsletter for updates on funded research, events, data science news, EDI, and trainee opportunities: shorturl.at/KynG2
👉 Follow us here and on X, LinkedIn and YouTube for the latest from #D2RMcGill
❄️ Happy Holidays from DNA to RNA! Wishing you all a festive holiday season filled with love and laughter. ❄️
☃️ Communication channels will not be monitored over the holidays (Dec 24- Jan 4), see you in the new year!
🧠 ❤️Join D2R for an EDI seminar about mental health in highly performant spaces in honour of the International Day for Persons with Disabilities
📅 December 3
🕐12–1 PM EST
📍Via Zoom
🔗 Register here: buff.ly/t1gvjy8
🧠 ❤️Join D2R for an EDI seminar about mental health in highly performant spaces in honour of the International Day for Persons with Disabilities
📅 December 3
🕐12–1 PM EST
📍Via Zoom
🔗 Register here: buff.ly/t1gvjy8
Join D2R for the next session of the D2R Investor Series with Inès Holzbaur, an experienced investor who will demystify the industry.
📅 28 November 2025
🕚 11:00 –1:00
📍Attend in person or via Zoom.
Register here: buff.ly/tcFaGmP
#Startups #Investing
💡 Curious about how D2R is turning its Equity, Diversity, and Inclusion (EDI) vision into action?
D2R’s EDI Action Plan was developed through a collaborative process, and outlines key initiatives across three key focus areas
🔗 Learn more:
🧬 D2R invests over $5.3 million in research and $3.9 million in training to advance RNA innovation across Canada over the next two years.
🔗 Foundational Projects | Cycle 2: buff.ly/rDRhJ85
🔗 Research in Motion Projects | Cycle 2: buff.ly/ZCjFser
#RNAResearch #Innovation
🧬 Professor Carl Ernst and his team are leading a groundbreaking RNA therapy project aimed at treating Schinzel-Giedion Syndrome supported by D2R’s Translational Impact Research program.
🔗 Learn more: buff.ly/0X51szG
#RareDisease #RNAtherapy
@mcgillscience.bsky.social
@theneuro.bsky.social
🎉 We are proud to launch our Equity, Diversity, and Inclusion (EDI) Action Plan!
✨EDI is at the core of D2R’s vision, and the document outlines our current and upcoming EDI initiatives across three key focus areas.
Read the Action Plan now: buff.ly/bEybZGg
🌿 At D2R, Indigenous engagement is at the heart of our approach. Hear from Philippe Gros, Loretta Loon, and Laurie Montour on how D2R is bringing Indigenous voices into RNA Research.
🔗 Watch now: buff.ly/uQ7jgKO
#IndigenousEngagement #RNAResearch
🧠 Imagine learning your child has a rare brain disorder—and no cure.
💡 With D2R support, Dr. Geneviève Bernard is developing RNA-based therapies to bring hope to families facing that reality.
🔗Read more: buff.ly/2iZEcB3
#RNA #RareDisease #Neuroscience #PrecisionMedicine
🌸 This Wednesday! 🌸
Join D2R , mcgillgci.bsky.social , the Quebec Breast Cancer Foundation, and Audace au Féminin for an inspiring evening to honour breast cancer awareness month!
📅 Wednesday, October 22, 2025
🕔 5:00 – 8:30 PM
📍 Atrium, Bellini Centre
Register: buff.ly/C64fHgE
